Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,227,009
+$601,347 QoQ
Shares Held
677,906
+46.3% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $14,127,751,631 across 522 Biotechnology names. OCGN ranks #231 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,235 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,602 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,921 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,358 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,942 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,160 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,002,681 | $331,757,055 |
All Filings in OCGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,227,009 | 677,906 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $625,662 | 463,454 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $473,619 | 290,564 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $593,347 | 611,698 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $595,438 | 843,397 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $760,419 | 944,621 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $953,735 | 961,427 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $972,871 | 627,659 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,015,823 | 619,405 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $170,295 | 296,169 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $112,326 | 280,821 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $189,838 | 349,614 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $339,301 | 397,780 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $580,703 | 446,697 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $753,442 | 423,284 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $2,755,573 | 605,621 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,595,793 | 640,083 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,730,231 | 589,070 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $161,567 | 23,795 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $118,560 | 64,787 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,946 | 15,955 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,246 | 14,759 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||